Phibro Animal Health Corp (NASDAQ:PAHC) VP Daniel M. Bendheim sold 6,576 shares of the business’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $40.03, for a total value of $263,237.28. Following the transaction, the vice president now owns 3,425 shares of the company’s stock, valued at $137,102.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Phibro Animal Health Corp (NASDAQ PAHC) traded up $0.70 on Monday, hitting $40.45. The stock had a trading volume of 99,710 shares, compared to its average volume of 98,011. Phibro Animal Health Corp has a 1 year low of $26.70 and a 1 year high of $40.85. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.75. The stock has a market cap of $1,630.00, a PE ratio of 23.65, a P/E/G ratio of 2.82 and a beta of 0.97.
Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Monday, February 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.06. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The firm had revenue of $205.90 million during the quarter, compared to analysts’ expectations of $194.90 million. During the same period in the prior year, the business earned $0.39 EPS. The company’s revenue for the quarter was up 7.5% compared to the same quarter last year. research analysts expect that Phibro Animal Health Corp will post 1.69 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Phibro Animal Health by 15.4% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 17,345 shares of the company’s stock worth $581,000 after purchasing an additional 2,321 shares in the last quarter. MetLife Investment Advisors LLC purchased a new position in shares of Phibro Animal Health in the 4th quarter worth about $335,000. Municipal Employees Retirement System of Michigan boosted its holdings in shares of Phibro Animal Health by 32.6% in the 4th quarter. Municipal Employees Retirement System of Michigan now owns 9,610 shares of the company’s stock worth $322,000 after purchasing an additional 2,360 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Phibro Animal Health by 64.3% in the 4th quarter. Millennium Management LLC now owns 419,998 shares of the company’s stock valued at $14,070,000 after acquiring an additional 164,424 shares during the last quarter. Finally, Teachers Advisors LLC lifted its stake in shares of Phibro Animal Health by 1.6% in the 4th quarter. Teachers Advisors LLC now owns 352,700 shares of the company’s stock valued at $11,815,000 after acquiring an additional 5,692 shares during the last quarter. Hedge funds and other institutional investors own 48.09% of the company’s stock.
PAHC has been the subject of several recent analyst reports. BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, March 3rd. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Monday, January 8th. Credit Suisse Group boosted their target price on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 6th. Morgan Stanley upped their price objective on Phibro Animal Health from $30.00 to $36.00 and gave the stock an “underweight” rating in a report on Wednesday, February 7th. Finally, ValuEngine upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Wednesday, February 28th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $38.20.
ILLEGAL ACTIVITY NOTICE: “Daniel M. Bendheim Sells 6,576 Shares of Phibro Animal Health Corp (PAHC) Stock” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/03/12/daniel-m-bendheim-sells-6576-shares-of-phibro-animal-health-corp-pahc-stock.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.